Celgene Corp (CELG) Tops Q3 EPS by 2c; Raises FY13 Outlook

October 24, 2013 7:33 AM EDT Send to a Friend
Celgene Corp (NASDAQ: CELG) reported Q3 EPS of $1.56, $0.02 better than the analyst estimate of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login